Ö. Besci Et Al. , "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys," PEDIATRIC CARDIOLOGY , vol.45, no.2, pp.228-239, 2024
Besci, Ö. Et Al. 2024. Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys. PEDIATRIC CARDIOLOGY , vol.45, no.2 , 228-239.
Besci, Ö., Akçura, Y. D., Acinikli, K., Kağızmanlı, G. A., Demir, K., Böber, E., ... Kır, M.(2024). Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys. PEDIATRIC CARDIOLOGY , vol.45, no.2, 228-239.
Besci, ÖZGE Et Al. "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys," PEDIATRIC CARDIOLOGY , vol.45, no.2, 228-239, 2024
Besci, ÖZGE Et Al. "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys." PEDIATRIC CARDIOLOGY , vol.45, no.2, pp.228-239, 2024
Besci, Ö. Et Al. (2024) . "Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys." PEDIATRIC CARDIOLOGY , vol.45, no.2, pp.228-239.
@article{article, author={ÖZGE BESCİ Et Al. }, title={Aromatase Inhibitors May Increase the Risk of Cardiometabolic Complications in Adolescent Boys}, journal={PEDIATRIC CARDIOLOGY}, year=2024, pages={228-239} }